Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Autism Spectrum Disorder (ASD) is a behaviorally defined neurodevelopmental condition. Symptoms of ASD cover the spectrum from mild qualitative differences in social interaction to severe communication and social and behavioral challenges that require lifelong support. Attempts at understanding the pathophysiology of ASD have been hampered by a multifactorial etiology that stretches the limits of current behavioral and cell based models. Recent progress has implicated numerous autism‐risk genes but efforts to gain a better understanding of the underlying biological mechanisms have seen slow progress. This is in part due to lack of appropriate models for complete molecular and pharmacological studies. The advent of induced pluripotent stem cells (iPSC) has reinvigorated efforts to establish more complete model systems that more reliably identify molecular pathways and predict effective drug targets and candidates in ASD. iPSCs are particularly appealing because they can be derived from human patients and controls for research purposes and provide a technology for the development of a personalized treatment regimen for ASD patients. The pluripotency of iPSCs allow them to be reprogrammed into a number of CNS cell types and phenotypically screened across many patients. This quality is already being exploited in protocols to generate 2‐dimensional (2‐D) and three‐dimensional (3‐D) models of neurons and developing brain structures. iPSC models make powerful platforms that can be interrogated using electrophysiology, gene expression studies, and other cell‐based quantitative assays. iPSC technology has limitations but when combined with other model systems has great potential for helping define the underlying pathophysiology of ASD. Autism Res 2016, 9: 513–535 . © 2015 International Society for Autism Research, Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · cited 2×
“…protocols that do not use dualSMAD inhibition to derive cortical neurons that include: activation of the Wnt and SHH pathways, and the direct conversion of fibroblasts into neurons by forced expression of neurogenin-2, among others [Li et al., 2009; Vierbuchen et al., 2010; Zhang et al., 2013].”
BackgroundThe contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585 · cited 2×
“Although a number of genes have been implicated in ASD, many de novo mutations can contribute to the ASD phenotype [Iossifov et al., 2014].”
BackgroundFMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 2×
“5% of those with ASD and is also found in ASD-related conditions Fragile-X syndrome and tuberous sclerosis [Darnell et al., 2011; Durand et al., 2006; Moessner et al., 2007; Gauthier et al., 2009; Sakai et al., 2011; Soorya et al., 2013].”
BackgroundInfluentialFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“One such study evaluated over 3,000 genes with an ASD link and found that copy number variants (CNV) tended to occur in genes involved in cell proliferation, cell motility and GTPASE/RAS signaling [Pinto et al., 2010].”
BackgroundGenetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism
Hallmayer, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.76 · Cited by 1,970 · cited 1×
“The NCI-60 paradigm can guide development of iPSC cell-based assays for ASD as, like cancer, there are multiple factors that contribute to development of the ASD phenotype [Bill & Geschwind, 2009; Hallmayer et al., 2011].”
MethodMeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
The development and application of optogenetics
Fenno, L., Yizhar, O., & Deisseroth, K. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113817 · Cited by 1,822 · cited 1×
“[Chen et al., 2013; Fenno et al., 2011; Grienberger & Konnerth, 2012; Jin et al., 2012; Kuner & Augustine, 2000; Mancuso et al., 2010] Voltage-Sensitive Dyes Can use optical techniques to record membrane voltage changes in a high-throughput platform.”
A conditional knockout resource for the genome-wide study of mouse gene function
Skarnes, W. C., Rosen, B., West, A. P., Koutsourakis, M., Bushell, W., Iyer, V., Mujica, A. O., Thomas, M., Harrow, J., Cox, T., et al. (2011) · Nature · doi:10.1038/nature10163 · Cited by 1,708
Rapid single-step induction of functional neurons from human pluripotent stem cells
Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.029 · Cited by 1,644 · cited 2×
“…protocols that do not use dualSMAD inhibition to derive cortical neurons that include: activation of the Wnt and SHH pathways, and the direct conversion of fibroblasts into neurons by forced expression of neurogenin-2, among others [Li et al., 2009; Vierbuchen et al., 2010; Zhang et al., 2013].”
BackgroundFunctional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture
Paşca, A. M., Sloan, S. A., Clarke, L. E., Tian, Y., Makinson, C. D., Huber, N., Kim, C. H., Park, J.-Y., O'Rourke, N. A., Nguyen, K. D., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3415 · Cited by 1,609 · cited 3×
“D culture system that revealed cortical lamination with a ventral zone, superficial and deep layers expressing TBR1, BRN2, SATB2, and CTIP2 at day 135 [Pasca et al., 2015].”
BackgroundInfluentialDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 2×
“5% of those with ASD and is also found in ASD-related conditions Fragile-X syndrome and tuberous sclerosis [Darnell et al., 2011; Durand et al., 2006; Moessner et al., 2007; Gauthier et al., 2009; Sakai et al., 2011; Soorya et al., 2013].”
BackgroundInfluentialEiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K., & Sasai, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.002 · Cited by 1,522 · cited 4×
“, 2013], recent work has focused intensely on development of 3-D cultures that recapitulate many of the functions of in vivo tissue [Eiraku et al., 2008; Lancaster et al., 2013; Mariani et al., 2012, 2015; Nestor et al., 2013, 2014; Sasai, 2013].”
BackgroundInfluentialSchwank, G., Koo, B.-K., Sasselli, V., Dekkers, J. F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C. K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.002 · Cited by 1,424 · cited 2×
“Examples of CRISPR gene correction have been shown for cystic fibrosis [Schwank et al., 2013], beta-thalassemia [Xie et al., 2014], facial anomalies syndrome [Horii, Tamura, Morita, Kimura, & Hatada, 2013], Duchenne muscular dystrophy [Li et al., 2015] and Huntington’s disease [An et al., 2014].”
BackgroundModelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders
Mariani, J., Coppola, G., Zhang, P., Abyzov, A., Provini, L., Tomasini, L., Amenduni, M., Szekely, A., Palejev, D., Wilson, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.034 · Cited by 1,149 · cited 7×
“[2015] showed that 3-D SFEBqs had an increased expression of GABAergic interneurons and progenitors as well as an increased number of synapses as marked by Synapsin I puncta and VGAT puncta, with no change in VGLUT [Mariani et al., 2015].”
BackgroundInfluentialKadoshima, T., Sakaguchi, H., Nakano, T., Soen, M., Ando, S., Eiraku, M., & Sasai, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315710110 · Cited by 999 · cited 2×
“Within these types of protocols, generalized cortical neurons can be derived, and can be distinguished into deep layer and superficial layer neuronal subtypes [Espuny-Camacho et al., 2013; Kadoshima et al., 2013; Shi, Kirwan, Smith, Robinson, & Livesey, 2012].”
BackgroundCommon genetic variants on 5p14.1 associate with autism spectrum disorders
Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J. T., Abrahams, B. S., Salyakina, D., Imielinski, M., Bradfield, J. P., Sleiman, P. M. A., et al. (2009) · Nature · doi:10.1038/nature07999 · Cited by 989 · cited 2×
“Many of these individuals show dysregulation of Ca21 channels that have also been implicated in ASD [Wang et al., 2009].”
BackgroundConvergence of genes and cellular pathways dysregulated in autism spectrum disorders
Pinto, D., Delaby, E., Merico, D., Barbosa, M., Merikangas, A., Klei, L., Thiruvahindrapuram, B., Xu, X., Ziman, R., Wang, Z., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.03.018 · Cited by 969
Forcing cells to change lineages
Graf, T., & Enver, T. (2009) · Nature · doi:10.1038/nature08533 · Cited by 899
Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses
Shi, Y., Kirwan, P., Smith, J., Robinson, H. P. C., & Livesey, F. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3041 · Cited by 813
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Carvajal-Vergara, X., Sevilla, A., D’Souza, S. L., Ang, Y.-S., Schaniel, C., Lee, D.-F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R., et al. (2010) · Nature · doi:10.1038/nature09005 · Cited by 690
Contribution of SHANK3 Mutations to Autism Spectrum Disorder
Moessner, R., Marshall, C. R., Sutcliffe, J. S., Skaug, J., Pinto, D., Vincent, J., Zwaigenbaum, L., Fernandez, B., Roberts, W., Szatmari, P., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/522590 · Cited by 681
Kirkeby, A., Grealish, S., Wolf, D. A., Nelander, J., Wood, J., Lundblad, M., Lindvall, O., & Parmar, M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.04.009 · Cited by 662 · cited 1×
“…to create NPCs from both ESCs and iPSCs have been directed towards differentiating glutamatergic-like [Chambers et al., 2009] and dopaminergic-like [Kirkeby et al., 2012; Kriks et al., 2011; C.M. Woodard et al., 2014; G.E. Woodard et al., 2014], neurons, dual-SMAD inhibition has been used to…”
MethodHan, X., Chen, M., Wang, F., Windrem, M., Wang, S., Shanz, S., Xu, Q., Oberheim, N. A., Bekar, L., Betstadt, S., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.015 · Cited by 635
Bozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D. L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A. M., Scattoni, M. L., et al. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-15 · Cited by 584 · cited 2×
“Additionally, these mice showed a significant decrease in social communication and interaction [Bozdagi et al., 2010].”
BackgroundSynaptic dysregulation in a human iPS cell model of mental disorders
Wen, Z., Nguyen, H. N., Guo, Z., Lalli, M. A., Wang, X., Su, Y., Kim, N.-S., Yoon, K.-J., Shin, J., Zhang, C., et al. (2014) · Nature · doi:10.1038/nature13716 · Cited by 549
Modeling human cortical development in vitro using induced pluripotent stem cells
Mariani, J., Simonini, M. V., Palejev, D., Tomasini, L., Coppola, G., Szekely, A. M., Horvath, T. L., & Vaccarino, F. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202944109 · Cited by 526 · cited 3×
“[2012] developed a 3-D system based on the Sasai quick aggregation method that mimicked aspects of early dorsal telencephalic development, with a significant enrichment in the expression of genes in the subventricular zone and dorsal pallium as well as with functions related to cortical neurogenesis, growth and axon g…”
BackgroundMethodParkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486 · cited 1×
“Due to species differences and other limitations, preclinical results from animal models have not been reliable and do not translate well at the clinical trial stage [Devine et al., 2011; Han et al., 2013].”
BackgroundVeres, A., Gosis, B. S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Cowan, C. A., Talkowski, M. E., & Musunuru, K. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.020 · Cited by 474 · cited 1×
“…technologies, there is some potential for unwanted editing at other sites in the genome in iPSC lines [Fu et al., 2013], although with proper optimization, these off target effects have shown to be low when looked at using whole genome sequencing [Smith et al., 2014; Veres et al., 2014].”
BackgroundSHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470 · cited 3×
“[2013] showed that there was a significant decrease in excitatory mEPSCs and fewer numbers of synapses in these patients, consistent with what is reported in animal models [Shcheglovitov et al., 2013].”
BackgroundResultInfluentialThe 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)
Phelan, K., & McDermid, H. E. (2011) · Molecular Syndromology · doi:10.1159/000334260 · Cited by 460
Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1
Kiskinis, E., Sandoe, J., Williams, L. A., Boulting, G. L., Moccia, R., Wainger, B. J., Han, S., Peng, T., Thams, S., Mikkilineni, S., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.03.004 · Cited by 441 · cited 1×
“Indeed, MEA recordings have been used to uncover phenotypes within iPSC models of Parkinson’s Disease and amyotrophic lateral sclerosis [Kiskinis et al., 2014; C.M. Woodard et al., 2014; G.E. Woodard et al., 2014].”
MethodXie, F., Ye, L., Chang, J. C., Beyer, A. I., Wang, J., Muench, M. O., & Kan, Y. W. (2014) · Genome Research · doi:10.1101/gr.173427.114 · Cited by 408
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389
Wilson, H. L., Wong, A. C. C., Shaw, S. R., Tse, W.-Y., Stapleton, G. A., Phelan, M. C., Hu, S., Marshall, J., & McDermid, H. E. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.575 · Cited by 377 · cited 1×
“22q13 deletion syndrome, otherwise known as PhelanMcDermid syndrome (PMDS) is an ASD-related neurodevelopmental disorder with most patients showing a global developmental delay that includes delayed or absent expressive speech and hypertonia [Phelan & McDermid, 2012; Wilson et al., 2003].”
BackgroundBoeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Liu, M.-L., Zang, T., Zou, Y., Chang, J. C., Gibson, J. R., Huber, K. M., & Zhang, C.-L. (2013) · Nature Communications · doi:10.1038/ncomms3183 · Cited by 343 · cited 2×
“Furthermore, these protocols can be used to derive glutamatergic neurons [Ambasudhan et al., 2011; Liu et al., 2013; Pang et al., 2011; Shi, Kirwan, & Livesey, 2012], astrocytes [Caiazzo et al., 2015; Gupta et al., 2012], and GABAergic neurons [Heinrich et al., 2010; Kim, Ross, Zaslavsky, & Ellis,…”
MethodSmith, C., Gore, A., Yan, W., Abalde-Atristain, L., Li, Z., He, C., Wang, Y., Brodsky, R. A., Zhang, K., Cheng, L., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.06.011 · Cited by 342 · cited 3×
“, 2013], although with proper optimization, these off target effects have shown to be low when looked at using whole genome sequencing [Smith et al., 2014; Veres et al., 2014].”
BackgroundAutism: Many Genes, Common Pathways?
Geschwind, D. H. (2008) · Cell · doi:10.1016/j.cell.2008.10.016 · Cited by 328 · cited 1×
“It is well known, however, that there are a large number of rare and de novo mutations that may play a role in the etiology of the disorder [Geschwind, 2008; Iossifov et al., 2014].”
BackgroundJung, C. B., Moretti, A., Mederos y Schnitzler, M., Iop, L., Storch, U., Bellin, M., Dorn, T., Ruppenthal, S., Pfeiffer, S., Goedel, A., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100194 · Cited by 327 · cited 1×
“Patient-derived iPSCs, when interrogated by HT assays, are providing insight into the effects of genetic disorders on the structure and function of affected organs [Carvajal-Vergara et al., INSAR Nestor et al./Human stem cells and autism research 525 2010; Jung et al., 2012].”
BackgroundBlatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013238809666 · Cited by 322 · cited 1×
“Neuronal dysregulation of the excitatory/inhibitory (E/I) balance in the central nervous system has been proposed as a possible pathway within the heterogeneous forms of ASD [Blatt et al., 2001; Hussman, 2001; Rubenstein & Merzenich, 2003].”
BackgroundSelf-citationChamberlain, S. J., Chen, P.-F., Ng, K. Y., Bourgois-Rocha, F., Lemtiri-Chlieh, F., Levine, E. S., & Lalande, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004487107 · Cited by 312 · cited 2×
“[2010] used methylation-specific PCR to successfully demonstrate that the epigenetic marks that underlie AS are robust to the iPSC reprogramming process in both males and females, and that AS iPSC-derived neurons expressed imprinted genes in the same manner as their progenitor cell [Chamberlain et al., 2010].”
BackgroundCheung, A. Y. L., Horvath, L. M., Grafodatskaya, D., Pasceri, P., Weksberg, R., Hotta, A., Carrel, L., & Ellis, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr093 · Cited by 271 · cited 6×
“…RTT-iPSC lines, suggesting cell-type of origin or reprogramming methods/efficiency may have an impact on iPSC gene expression, and should be considered when investigating disorders of gene expression (as may be the case with ASD) [Ananiev et al., 2011; Cheung et al., 2011; Marchetto et al., 2010].”
BackgroundMethodInfluentialPaull, D., Sevilla, A., Zhou, H., Hahn, A. K., Kim, H., Napolitano, C., Tsankov, A., Shang, L., Krumholz, K., Jagadeesan, P., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3507 · Cited by 263 · cited 3×
“Issues such as a lack of unified protocols, suboptimal yield purity and genetic variability continue to hamper efforts to scale up to HT screening [Paull et al., 2015; Rajamohan et al., 2013].”
BackgroundMethodHussman, J. P. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1010715619091 · Cited by 263
Self-citationModeling non-syndromic autism and the impact of TRPC6 disruption in human neurons
Griesi-Oliveira, K., Acab, A., Gupta, A. R., Sunaga, D. Y., Chailangkarn, T., Nicol, X., Nunez, Y., Walker, M. F., Murdoch, J. D., Sanders, S. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.141 · Cited by 236
Hussman, J. P., Chung, R.-H., Griswold, A. J., Jaworski, J. M., Salyakina, D., Ma, D., Konidari, I., Whitehead, P. L., Vance, J. M., Martin, E. R., et al. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-1 · Cited by 231
Self-citationProtein interactome reveals converging molecular pathways among autism disorders
Sakai, Y., Shaw, C. A., Dawson, B. C., Dugas, D. V., Al-Mohtaseb, Z., Hill, D. E., & Zoghbi, H. Y. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002166 · Cited by 226 · cited 2×
“5% of those with ASD and is also found in ASD-related conditions Fragile-X syndrome and tuberous sclerosis [Darnell et al., 2011; Durand et al., 2006; Moessner et al., 2007; Gauthier et al., 2009; Sakai et al., 2011; Soorya et al., 2013].”
BackgroundInfluentialA Genome‐wide Association Study of Autism Reveals a Common Novel Risk Locus at 5p14.1
Ma, D., Salyakina, D., Jaworski, J. M., Konidari, I., Whitehead, P. L., Andersen, A. N., Hoffman, J. D., Slifer, S. H., Hedges, D. J., Cukier, H. N., et al. (2009) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00523.x · Cited by 221
Self-citationHuman Stem Cell-Derived Spinal Cord Astrocytes with Defined Mature or Reactive Phenotypes
Roybon, L., Lamas, N. J., Garcia-Diaz, A., Yang, E. J., Sattler, R., Jackson-Lewis, V., Kim, Y. A., Kachel, C. A., Rothstein, J. D., Przedborski, S., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.021 · Cited by 208 · cited 1×
“In addition to the induction of cortical neurons and neuron sub-types, dual-SMAD inhibition has been utilized to create pure populations of astrocytes [Krencik & Zhang, 2011; Roybon et al., 2013].”
MethodDISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms
Nakata, K., Lipska, B. K., Hyde, T. M., Ye, T., Newburn, E. N., Morita, Y., Vakkalanka, R., Barenboim, M., Sei, Y., Weinberger, D. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903413106 · Cited by 182 · cited 1×
“DISC1 mutations and variations in gene expression have been associated with SCZ phenotypes in mice and postmortem brain tissue [Nakata et al., 2009].”
BackgroundBarrett, C. F., & Tsien, R. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710501105 · Cited by 174
Zhang, D., Pekkanen-Mattila, M., Shahsavani, M., Falk, A., Teixeira, A. I., & Herland, A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.028 · Cited by 171
Genetic advances in autism: heterogeneity and convergence on shared pathways
Bill, B. R., & Geschwind, D. H. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.004 · Cited by 164
Nevison, C. D. (2014) · Environmental Health · doi:10.1186/1476-069x-13-73 · Cited by 111 · cited 1×
“Longitudinal analysis suggests an increase in the prevalence of ASD since 1980s [Scott et al., 2002; Nevison, 2014].”
BackgroundDrug discovery for autism spectrum disorder: challenges and opportunities
Ghosh, A., Michalon, A., Lindemann, L., Fontoura, P., & Santarelli, L. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4102 · Cited by 108
Fluri, D. A., Tonge, P. D., Song, H., Baptista, R. P., Shakiba, N., Shukla, S., Clarke, G., Nagy, A., & Zandstra, P. W. (2012) · Nature Methods · doi:10.1038/nmeth.1939 · Cited by 106 · cited 1×
“The prohibitive cost of iPSC maintenance has catalyzed work to identify alternate reagents or pathways that can maintain the characteristics of iPSCs yet significantly reduce the cost of maintenance [Fluri et al., 2012; Schroeder et al., 2005; Zanella, Lorens, & Link, 2010].”
BackgroundOptimizing neuronal differentiation from induced pluripotent stem cells to model ASD
Kim, D.-S., Ross, P. J., Zaslavsky, K., & Ellis, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00109 · Cited by 70
Phenotypic characterization of nonsocial behavioral impairment in neurexin 1α knockout rats.
Esclassan, F., Francois, J., Phillips, K. G., Loomis, S., & Gilmour, G. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000024 · Cited by 52
Cited by
Current perspectives in autism spectrum disorder: from genes to therapy
Chahrour, M., O'Roak, B. J., Santini, E., Samaco, R. C., Kleiman, R. J., & Manzini, M. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2335-16.2016 · Cited by 54
Development and Characterization of Human Cerebral Organoids: An Optimized Protocol
Yakoub, A. M., & Sadek, M. (2018) · Cell Transplantation · doi:10.1177/0963689717752946 · Cited by 47
Flaherty, E. K., & Brennand, K. J. (2017) · Brain Research · doi:10.1016/j.brainres.2015.11.009 · Cited by 19
Metadata
- Authors
- Nestor, M. W., Phillips, A. W., Artimovich, E., Nestor, J. E., Hussman, J. P., & Blatt, G. J.
- Venue
- Autism Research
- Publisher
- Wiley
- Published
- 2015-10
- Volume
- 9
- Issue
- 5
- Pages
- 513-535
- ISSN
- 1939-3792 (ISSN-L)
- 1939-3806
- OpenAlex
- W1833799144
- Cited by
- 35
- References
- 61
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.